Clarissa Souza
Assistant Professor of Dermatology
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (7)
Year:
2026
Objective To determine if and how oral itraconazole alters the gastrointestinal microbiome of cats. Methods This was a single-arm, longitudinal exploratory study performed in a university setting. Healthy cats were administered 5 mg/kg/day of itraconazole solution orally with food during alternating weeks over a 5-week time period. Rectal swabs were collected at 2 time points before treatment and serially during and after treatment over 31 weeks. Bacterial and fungal populations were quantified by 16S and internal transcribed spacer 3 and 4 sequencing, respectively. Changes in α diversity, β diversity, and differential abundance were evaluated over time. Results There were no significant changes in bacterial α diversity, β diversity ( R 2 = 0.0077; P = .550), or relative abundance between the 2 pretreatment time points indicating stable microbial populations before itraconazole exposure in 16 cats. Time was a significant determinant of β diversity during and after itraconazole treatment ( R 2 = 0.0181; P = .002), and several α-diversity indices significantly decreased in the posttreatment timeframe. Ruminococcus torques (−1.916; 95% CI, −2.971 to −0.861), Acidaminococcus spp (−1.291; 95%, CI −1.866 to −0.716), and Blautia hansenii (−1.475, 95% CI, −2.295 to −0.691) relative abundances were significantly decreased at weeks 1, 5, and 9, respectively. The final fungal internal transcribed spacer dataset only included 5 taxa limiting analysis and interpretation. Conclusions These findings provide preliminary evidence for possible dysbiosis in the feline gastrointestinal tract during itraconazole treatment. However, many changes in differential abundance were small and no longer significant posttreatment. Clinical Relevance Itraconazole administration might induce gastrointestinal bacterial dysbiosis in cats. Alternate methods for fungal microbiome assessment should be used in future feline studies.
Year:
2026
Year:
2026
Year:
2026
Background Ichthyoses represent a heterogeneous group of cornification disorders characterised by epidermal scaling. Objectives To describe the clinical, histopathological and genetic analysis of a Labrador retriever with nonepidermolytic ichthyosis, and the results of a population screening for a newly detected PNPLA1 genomic duplication. Animals Two 7‐year‐old male littermates, 531 population samples. Materials and Methods Clinical and histopathological analysis, whole genome sequencing and digital PCR‐based genotyping were performed. Results Generalised scaling and histological laminar orthokeratotic hyperkeratosis confirmed the ichthyosis diagnosis on Dog 1. Dog 2 showed mild clinical signs possibly associated with allergies and not ichthyosis. The genome of Dog 1 was sequenced and compared to 1469 genetically diverse control genomes. The analysis identified a 6099‐bp duplication spanning three internal exons of the PNPLA1 gene, which is predicted to result in an altered C‐terminal tail of the protein, NP_001277038.2:p.(E558Lfs*17). Dog 2 had a heterozygous genotype and carried one copy of the duplicated PNPLA1 allele. Of the screened 531 additional Labrador retrievers, 491 were homozygous wild‐type, 36 were heterozygous carriers and four carried the duplication in a homozygous state. Conclusions and Clinical Relevance Previously identified PNPLA1 variants cause autosomal recessive ichthyosis in golden retrievers and humans. Given the well‐established function of PNPLA1 , the identified genomic duplication represents a likely candidate causal variant for the observed ichthyosis in the examined Labrador retriever. This is the first report of a new form of autosomal recessive ichthyosis in Labrador retrievers, which provides the basis for genetic testing.
Year:
2025
Background Topical therapy is preferred for otitis externa (OE) in dogs. Otic products commonly contain glucocorticoids that can be systemically absorbed and possibly interfere with diagnostic tests such as intradermal testing (IDT). Hypothesis/Objectives To determine the effect of a long‐lasting otic solution containing mometasone furoate (MF) on IDT immediate reactions and to determine withdrawal time before IDT. Animals Seventeen dogs with healthy ears (Group 1) and 12 with OE (Group 2). Materials and Methods Intradermal injections of histamine, anticanine‐immunoglobulin (Ig)E and saline were subjectively and objectively evaluated before treatment and weekly for 6 weeks, after a single application of a long‐lasting otic solution containing MF. Results Statistically significant reductions in the mean subjective histamine scores after application of MF were observed at Weeks 1 ( p = 0.012) and 2 ( p = 0.028) in Group 1, and Weeks 1 ( p = 0.00066), 2 ( p = 0.02) and 4 ( p = 0.034) in Group 2. Mean histamine objective scores were significantly reduced in Weeks 1 ( p = 0.042), 2 ( p = 0.0009), 3 ( p = 0.001) and 5 ( p = 0.018) in Group 1 only. The mean subjective anticanine‐IgE scores were significantly reduced in Week 1 in both groups ( p = 0.003, p = 0.0066), respectively. There were no significant changes in the mean anticanine‐IgE objective score in either group. Conclusions and Clinical Relevance Application of a long‐lasting otic solution containing MF can interfere with IDT immediate reactions in healthy and OE dogs. Based on the subjective evaluation, IDT can be performed ≥2 weeks after application of the otic solution in healthy dogs, and ≥4 weeks in dogs with OE.
Year:
2024
Year:
2023
Collaborators (7)
Chien-Che Hung
Clinical Associate Professor
University of Illinois at Urbana-Champaign
Guilherme Verocai
Clinical Assistant Professor
Texas A&M University
Joel Tyndall
University of Otago
Patrick Barko
University of Illinois at Urbana-Champaign
Tosso Leeb
Professor
University of Bern
Lois Hoyer
Professor
University of Illinois Urbana–Champaign
Jennifer M. Reinhart
Assistant Professor
University of Illinois at Urbana-Champaign
Make your next move.
Prepare your application
Review drafts before you send them.